ARCHIVES

ODAC Meeting: Further Restrictions Likely On ESA Use; Changes Advocated by ODAC May Cut Market By 40-50 Percent.

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | March 21, 2008

Download PDF Visit The Full Archive

Related Articles

NCI Expects 200 CCP applications; Grand Rapids Workshop To Offer Last Chance to Ask Questions

September 24, 1982

Cancer Letter Editor Finalist for Loeb Award

May 16, 2003

In Surgery vs Radiotherapy, Outcome Differences Equalize After 15 Years Follow-up

February 22, 2013

Et2’s Referral Guidelines

July 23, 1993

Diagnosis-Treatment Cidac contract Gets Recompetition Okay

December 16, 1983

Two Children Achieve Remission With CD19 Immunotherapy

March 29, 2013